Literature DB >> 34930024

Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria.

Sanchita Das1, Karen Bush2.   

Abstract

The emergence and spread of antimicrobial resistance, especially in Gram-negative bacteria, has led to significant morbidity and increased cost of health care. Large surveillance studies such as the one performed by the Antibiotic Resistance Laboratory Network are immensely valuable in understanding the scope of resistance mechanisms, especially among carbapenemase-producing Gram-negative bacteria. However, the routine laboratory detection of carbapenemases in these bacteria remains challenging and requires further optimization.

Entities:  

Keywords:  Gram negative; carbapenemase detection; surveillance

Mesh:

Substances:

Year:  2021        PMID: 34930024      PMCID: PMC8846484          DOI: 10.1128/aac.02299-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  8 in total

1.  Real-world antibiotic needs for resistant Gram-negative infections.

Authors:  Margaret A Fitzpatrick
Journal:  Lancet Infect Dis       Date:  2020-06-04       Impact factor: 25.071

Review 2.  Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Authors:  Sandra S Richter; Dror Marchaim
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

3.  Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.

Authors:  Sameer S Kadri; Jennifer Adjemian; Yi Ling Lai; Alicen B Spaulding; Emily Ricotta; D Rebecca Prevots; Tara N Palmore; Chanu Rhee; Michael Klompas; John P Dekker; John H Powers; Anthony F Suffredini; David C Hooper; Scott Fridkin; Robert L Danner
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

4.  In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014.

Authors:  James A Karlowsky; Sibylle H Lob; Krystyna M Kazmierczak; Robert E Badal; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

5.  Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017.

Authors:  Krystyna M Kazmierczak; James A Karlowsky; Boudewijn L M de Jonge; Gregory G Stone; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

6.  Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.

Authors:  Sarah Sabour; Jennifer Y Huang; Amelia Bhatnagar; Sarah E Gilbert; Maria Karlsson; David Lonsway; Joseph D Lutgring; J Kamile Rasheed; Alison Laufer Halpin; Richard A Stanton; Stephanie Gumbis; Christopher A Elkins; Allison C Brown
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

Review 7.  Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.

Authors:  Glen T Hansen
Journal:  Infect Dis Ther       Date:  2021-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.